Role of cyclic AMP in prostaglandin mediated responses in the neural retina

S. E. Ohia, Catherine A. Opere, L. Tang, K. Al-Zadjali

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Exogenous prostaglandin (PGs) have been shown to inhibit dopamine (DA) release from the rabbit retina via an effect on presynaptic EP 3-receptors. In the present study, we investigated the possible involvement of cyclic AMP in DA release and in the prostanoid receptor mediated regulation of DA release from the neural retina. Both forskolin and 8-bromo-cyclic AMP enhanced field stimulation-evoked [ 3H]DA release from isolated, superfused rabbit retinas without affecting basal tracer efflux suggesting that presynaptic cyclic AMP may be involved in the pathway leading to DA release. Forskolin attenuated inhibition of evoked [ 3H]DA release caused by low but not high concentrations of PGE 2. Both PGE 2 and sulprostone had no significant effect on basal cyclic AMP levels but inhibited forskolin-stimulated cyclic AMP formation. Furthermore, sulprostone was more potent than PGE 2 in attenuating forskolin-activated cyclic AMP production. The inhibition of forskolin-elevated cyclic AMP levels caused by PGE 2 was, however, unaffected by the EP 1-receptor antagonist, AH6809. We conclude that the regulation of DA release by presynaptic prostanoid EP 3-receptors may be mediated, at least in part, through an inhibitory effect of adenylyl cyclase.

Original languageEnglish
Pages (from-to)73-81
Number of pages9
JournalJournal of Ocular Pharmacology and Therapeutics
Volume11
Issue number1
StatePublished - 1995

Fingerprint

Cyclic AMP
Prostaglandins
Retina
Dopamine
Colforsin
Prostaglandins E
Rabbits
8-Bromo Cyclic Adenosine Monophosphate
Adenylyl Cyclases

All Science Journal Classification (ASJC) codes

  • Ophthalmology
  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Role of cyclic AMP in prostaglandin mediated responses in the neural retina. / Ohia, S. E.; Opere, Catherine A.; Tang, L.; Al-Zadjali, K.

In: Journal of Ocular Pharmacology and Therapeutics, Vol. 11, No. 1, 1995, p. 73-81.

Research output: Contribution to journalArticle

@article{13fa196a871f4644b3dffc83832d796e,
title = "Role of cyclic AMP in prostaglandin mediated responses in the neural retina",
abstract = "Exogenous prostaglandin (PGs) have been shown to inhibit dopamine (DA) release from the rabbit retina via an effect on presynaptic EP 3-receptors. In the present study, we investigated the possible involvement of cyclic AMP in DA release and in the prostanoid receptor mediated regulation of DA release from the neural retina. Both forskolin and 8-bromo-cyclic AMP enhanced field stimulation-evoked [ 3H]DA release from isolated, superfused rabbit retinas without affecting basal tracer efflux suggesting that presynaptic cyclic AMP may be involved in the pathway leading to DA release. Forskolin attenuated inhibition of evoked [ 3H]DA release caused by low but not high concentrations of PGE 2. Both PGE 2 and sulprostone had no significant effect on basal cyclic AMP levels but inhibited forskolin-stimulated cyclic AMP formation. Furthermore, sulprostone was more potent than PGE 2 in attenuating forskolin-activated cyclic AMP production. The inhibition of forskolin-elevated cyclic AMP levels caused by PGE 2 was, however, unaffected by the EP 1-receptor antagonist, AH6809. We conclude that the regulation of DA release by presynaptic prostanoid EP 3-receptors may be mediated, at least in part, through an inhibitory effect of adenylyl cyclase.",
author = "Ohia, {S. E.} and Opere, {Catherine A.} and L. Tang and K. Al-Zadjali",
year = "1995",
language = "English",
volume = "11",
pages = "73--81",
journal = "Journal of Ocular Pharmacology and Therapeutics",
issn = "1080-7683",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Role of cyclic AMP in prostaglandin mediated responses in the neural retina

AU - Ohia, S. E.

AU - Opere, Catherine A.

AU - Tang, L.

AU - Al-Zadjali, K.

PY - 1995

Y1 - 1995

N2 - Exogenous prostaglandin (PGs) have been shown to inhibit dopamine (DA) release from the rabbit retina via an effect on presynaptic EP 3-receptors. In the present study, we investigated the possible involvement of cyclic AMP in DA release and in the prostanoid receptor mediated regulation of DA release from the neural retina. Both forskolin and 8-bromo-cyclic AMP enhanced field stimulation-evoked [ 3H]DA release from isolated, superfused rabbit retinas without affecting basal tracer efflux suggesting that presynaptic cyclic AMP may be involved in the pathway leading to DA release. Forskolin attenuated inhibition of evoked [ 3H]DA release caused by low but not high concentrations of PGE 2. Both PGE 2 and sulprostone had no significant effect on basal cyclic AMP levels but inhibited forskolin-stimulated cyclic AMP formation. Furthermore, sulprostone was more potent than PGE 2 in attenuating forskolin-activated cyclic AMP production. The inhibition of forskolin-elevated cyclic AMP levels caused by PGE 2 was, however, unaffected by the EP 1-receptor antagonist, AH6809. We conclude that the regulation of DA release by presynaptic prostanoid EP 3-receptors may be mediated, at least in part, through an inhibitory effect of adenylyl cyclase.

AB - Exogenous prostaglandin (PGs) have been shown to inhibit dopamine (DA) release from the rabbit retina via an effect on presynaptic EP 3-receptors. In the present study, we investigated the possible involvement of cyclic AMP in DA release and in the prostanoid receptor mediated regulation of DA release from the neural retina. Both forskolin and 8-bromo-cyclic AMP enhanced field stimulation-evoked [ 3H]DA release from isolated, superfused rabbit retinas without affecting basal tracer efflux suggesting that presynaptic cyclic AMP may be involved in the pathway leading to DA release. Forskolin attenuated inhibition of evoked [ 3H]DA release caused by low but not high concentrations of PGE 2. Both PGE 2 and sulprostone had no significant effect on basal cyclic AMP levels but inhibited forskolin-stimulated cyclic AMP formation. Furthermore, sulprostone was more potent than PGE 2 in attenuating forskolin-activated cyclic AMP production. The inhibition of forskolin-elevated cyclic AMP levels caused by PGE 2 was, however, unaffected by the EP 1-receptor antagonist, AH6809. We conclude that the regulation of DA release by presynaptic prostanoid EP 3-receptors may be mediated, at least in part, through an inhibitory effect of adenylyl cyclase.

UR - http://www.scopus.com/inward/record.url?scp=0028999298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028999298&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 73

EP - 81

JO - Journal of Ocular Pharmacology and Therapeutics

JF - Journal of Ocular Pharmacology and Therapeutics

SN - 1080-7683

IS - 1

ER -